The data for 2024 to 2028 shows a decreasing trend in the mortality rate for malignant neoplasms of the colon, rectum, and anus in Japan, declining from 23.5 to 22.9 deaths per hundred thousand persons. Considering actual data up to 2023, these figures point to an ongoing slight annual reduction. From 2024 to 2025, the year-on-year decrease is approximately 0.43%, followed by further minor reductions each subsequent year. The compound annual growth rate (CAGR) from 2024 to 2028 is estimated to be around -0.64%.
Future trends to watch for include advancements in medical technology and treatment protocols that may further decrease mortality rates. Additionally, public health initiatives aimed at early detection and prevention could play a significant role in reducing these rates even further. Monitoring demographic shifts and lifestyle changes will also be crucial in forecasting long-term impacts on the mortality rate.
